Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers and payers in the U.S.UK ...
John Authers of this parish points out that corporate commitment to ESG had been waning long before Trump’s election in part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback